Home/NeuCyte/Tao Huang

TH

Tao Huang

Chief Executive Officer and President

Therapeutic Areas

Alzheimer's Disease ALS/FTD Rare Neurological Diseases Epilepsy Autism Neurodegenerative Diseases

NeuCyte Pipeline

Drug	Indication	Phase
Internal Discovery Programs	Neurological disorders (AD, ALS/FTD, epilepsy, autism, rare diseases)	Discovery

Leadership Team at NeuCyte

Senior Director, Head of Neuroscience and Rare Diseases

View full NeuCyte profile